Dealmaking on the Rise?
If the conditions prove optimal, 2025 could be a prosperous year for bio/pharma business deals.
Drug Solutions Podcast: Forecasting Pharma’s Future
This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.
Zentalis to Cut 40% of Workforce Under Strategic Restructuring Plan
The reduction is expected to be “substantially completed,” the San Diego-based company said, in the second quarter of 2025.
Drug Solutions Podcast: Realizing AI’s Potential
This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.
European Drug Shortage Monitoring Platform Fully Operational
The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.
Lantheus Announces Agreement to Acquire Evergreen Theragnostics
The deal is being made for an all-cash price of $250 million, but with an additional $752.5 million available in potential milestone payments.
